Figure 1.

Cumulative incidence of human adenovirus (HAdV) infection and HAdV viremia in pediatric recipients with allogeneic hematopoietic cell transplantation. The cumulative incidence rates of HAdV infection and viremia at 1 year after HCT were 20% and 6% and 2 years after HCT were 23% and 8%, respectively. Median time to first HAdV infection after HCT was 113 days (range, 7‐596 days), whereas median time to first HAdV viremia was 221 days (range, 7‐596 days). HCT, hematopoietic cell transplantation